nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2B6—Sorafenib—thyroid cancer	0.156	0.246	CbGbCtD
Clobazam—CYP2C19—Sorafenib—thyroid cancer	0.0994	0.156	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—thyroid cancer	0.0949	0.149	CbGbCtD
Clobazam—ABCB1—Sorafenib—thyroid cancer	0.0802	0.126	CbGbCtD
Clobazam—CYP3A4—Vandetanib—thyroid cancer	0.0797	0.125	CbGbCtD
Clobazam—ABCB1—Doxorubicin—thyroid cancer	0.0487	0.0764	CbGbCtD
Clobazam—CYP3A4—Sorafenib—thyroid cancer	0.048	0.0755	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—thyroid cancer	0.0292	0.0458	CbGbCtD
Clobazam—Balance disorder—Vandetanib—thyroid cancer	0.0123	0.0409	CcSEcCtD
Clobazam—Respiratory failure—Vandetanib—thyroid cancer	0.00683	0.0228	CcSEcCtD
Clobazam—Lethargy—Vandetanib—thyroid cancer	0.00497	0.0166	CcSEcCtD
Clobazam—Dysphagia—Vandetanib—thyroid cancer	0.00421	0.014	CcSEcCtD
Clobazam—Bronchitis—Vandetanib—thyroid cancer	0.00404	0.0135	CcSEcCtD
Clobazam—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00391	0.0131	CcSEcCtD
Clobazam—Pneumonia—Vandetanib—thyroid cancer	0.00377	0.0126	CcSEcCtD
Clobazam—Infestation NOS—Vandetanib—thyroid cancer	0.00375	0.0125	CcSEcCtD
Clobazam—Infestation—Vandetanib—thyroid cancer	0.00375	0.0125	CcSEcCtD
Clobazam—Depression—Vandetanib—thyroid cancer	0.00374	0.0125	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00372	0.0124	CcSEcCtD
Clobazam—Urinary tract infection—Vandetanib—thyroid cancer	0.00364	0.0122	CcSEcCtD
Clobazam—Visual impairment—Vandetanib—thyroid cancer	0.00324	0.0108	CcSEcCtD
Clobazam—Erythema multiforme—Vandetanib—thyroid cancer	0.00318	0.0106	CcSEcCtD
Clobazam—Eye disorder—Vandetanib—thyroid cancer	0.00315	0.0105	CcSEcCtD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00313	0.0489	CbGpPWpGaD
Clobazam—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00296	0.00987	CcSEcCtD
Clobazam—Mental disorder—Vandetanib—thyroid cancer	0.00295	0.00985	CcSEcCtD
Clobazam—Malnutrition—Vandetanib—thyroid cancer	0.00293	0.00979	CcSEcCtD
Clobazam—Dysphagia—Sorafenib—thyroid cancer	0.00284	0.00947	CcSEcCtD
Clobazam—Muscle spasms—Vandetanib—thyroid cancer	0.00282	0.00941	CcSEcCtD
Clobazam—Vision blurred—Vandetanib—thyroid cancer	0.00276	0.00922	CcSEcCtD
Clobazam—Tremor—Vandetanib—thyroid cancer	0.00275	0.00917	CcSEcCtD
Clobazam—Cough—Vandetanib—thyroid cancer	0.00256	0.00854	CcSEcCtD
Clobazam—Pneumonia—Sorafenib—thyroid cancer	0.00254	0.0085	CcSEcCtD
Clobazam—Infestation NOS—Sorafenib—thyroid cancer	0.00253	0.00845	CcSEcCtD
Clobazam—Infestation—Sorafenib—thyroid cancer	0.00253	0.00845	CcSEcCtD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00252	0.0394	CbGpPWpGaD
Clobazam—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00251	0.00838	CcSEcCtD
Clobazam—Anxiety—Vandetanib—thyroid cancer	0.00249	0.0083	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00248	0.00827	CcSEcCtD
Clobazam—Dry mouth—Vandetanib—thyroid cancer	0.00244	0.00815	CcSEcCtD
Clobazam—Infection—Vandetanib—thyroid cancer	0.00238	0.00793	CcSEcCtD
Clobazam—Nervous system disorder—Vandetanib—thyroid cancer	0.00235	0.00783	CcSEcCtD
Clobazam—Thrombocytopenia—Vandetanib—thyroid cancer	0.00234	0.00782	CcSEcCtD
Clobazam—Nystagmus—Epirubicin—thyroid cancer	0.00234	0.00781	CcSEcCtD
Clobazam—Skin disorder—Vandetanib—thyroid cancer	0.00232	0.00776	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00218	0.00728	CcSEcCtD
Clobazam—Nystagmus—Doxorubicin—thyroid cancer	0.00216	0.00723	CcSEcCtD
Clobazam—Insomnia—Vandetanib—thyroid cancer	0.00216	0.00722	CcSEcCtD
Clobazam—Erythema multiforme—Sorafenib—thyroid cancer	0.00215	0.00717	CcSEcCtD
Clobazam—Decreased appetite—Vandetanib—thyroid cancer	0.00208	0.00694	CcSEcCtD
Clobazam—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00206	0.0069	CcSEcCtD
Clobazam—Fatigue—Vandetanib—thyroid cancer	0.00206	0.00689	CcSEcCtD
Clobazam—Constipation—Vandetanib—thyroid cancer	0.00205	0.00683	CcSEcCtD
Clobazam—Blood disorder—Epirubicin—thyroid cancer	0.002	0.00668	CcSEcCtD
Clobazam—Mental disorder—Sorafenib—thyroid cancer	0.00199	0.00664	CcSEcCtD
Clobazam—Malnutrition—Sorafenib—thyroid cancer	0.00198	0.0066	CcSEcCtD
Clobazam—Delirium—Epirubicin—thyroid cancer	0.00194	0.00649	CcSEcCtD
Clobazam—Muscle spasms—Sorafenib—thyroid cancer	0.0019	0.00635	CcSEcCtD
Clobazam—Body temperature increased—Vandetanib—thyroid cancer	0.00189	0.00631	CcSEcCtD
Clobazam—Blood disorder—Doxorubicin—thyroid cancer	0.00185	0.00618	CcSEcCtD
Clobazam—Anaemia—Sorafenib—thyroid cancer	0.00183	0.0061	CcSEcCtD
Clobazam—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.0018	0.0281	CbGpPWpGaD
Clobazam—Delirium—Doxorubicin—thyroid cancer	0.0018	0.006	CcSEcCtD
Clobazam—Leukopenia—Sorafenib—thyroid cancer	0.00177	0.00591	CcSEcCtD
Clobazam—Dysarthria—Epirubicin—thyroid cancer	0.00177	0.0059	CcSEcCtD
Clobazam—Cough—Sorafenib—thyroid cancer	0.00172	0.00576	CcSEcCtD
Clobazam—Asthenia—Vandetanib—thyroid cancer	0.00172	0.00573	CcSEcCtD
Clobazam—Pruritus—Vandetanib—thyroid cancer	0.00169	0.00565	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—SLC5A5—thyroid cancer	0.00169	0.0264	CbGpPWpGaD
Clobazam—Myalgia—Sorafenib—thyroid cancer	0.00168	0.00562	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00167	0.00558	CcSEcCtD
Clobazam—Dry mouth—Sorafenib—thyroid cancer	0.00165	0.0055	CcSEcCtD
Clobazam—Diarrhoea—Vandetanib—thyroid cancer	0.00164	0.00546	CcSEcCtD
Clobazam—Dysarthria—Doxorubicin—thyroid cancer	0.00163	0.00546	CcSEcCtD
Clobazam—Infection—Sorafenib—thyroid cancer	0.0016	0.00535	CcSEcCtD
Clobazam—Nervous system disorder—Sorafenib—thyroid cancer	0.00158	0.00528	CcSEcCtD
Clobazam—Dizziness—Vandetanib—thyroid cancer	0.00158	0.00528	CcSEcCtD
Clobazam—Thrombocytopenia—Sorafenib—thyroid cancer	0.00158	0.00528	CcSEcCtD
Clobazam—Skin disorder—Sorafenib—thyroid cancer	0.00157	0.00523	CcSEcCtD
Clobazam—Anorexia—Sorafenib—thyroid cancer	0.00154	0.00514	CcSEcCtD
Clobazam—Vomiting—Vandetanib—thyroid cancer	0.00152	0.00508	CcSEcCtD
Clobazam—Rash—Vandetanib—thyroid cancer	0.00151	0.00504	CcSEcCtD
Clobazam—Dermatitis—Vandetanib—thyroid cancer	0.00151	0.00503	CcSEcCtD
Clobazam—Headache—Vandetanib—thyroid cancer	0.0015	0.005	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00147	0.00491	CcSEcCtD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00142	0.0222	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00142	0.0222	CbGpPWpGaD
Clobazam—Nausea—Vandetanib—thyroid cancer	0.00142	0.00474	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—RXRA—thyroid cancer	0.00142	0.0222	CbGpPWpGaD
Clobazam—Decreased appetite—Sorafenib—thyroid cancer	0.0014	0.00468	CcSEcCtD
Clobazam—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00139	0.00465	CcSEcCtD
Clobazam—Fatigue—Sorafenib—thyroid cancer	0.00139	0.00465	CcSEcCtD
Clobazam—SLC6A11—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00138	0.0215	CbGpPWpGaD
Clobazam—Constipation—Sorafenib—thyroid cancer	0.00138	0.00461	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—SLC5A5—thyroid cancer	0.00136	0.0213	CbGpPWpGaD
Clobazam—Increased appetite—Epirubicin—thyroid cancer	0.00129	0.00431	CcSEcCtD
Clobazam—Urticaria—Sorafenib—thyroid cancer	0.00128	0.00428	CcSEcCtD
Clobazam—Body temperature increased—Sorafenib—thyroid cancer	0.00128	0.00426	CcSEcCtD
Clobazam—CYP2C18—Metapathway biotransformation—CHST14—thyroid cancer	0.00127	0.0199	CbGpPWpGaD
Clobazam—Lethargy—Epirubicin—thyroid cancer	0.00124	0.00413	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—NRG1—thyroid cancer	0.00123	0.0192	CbGpPWpGaD
Clobazam—Diplopia—Epirubicin—thyroid cancer	0.00121	0.00405	CcSEcCtD
Clobazam—Osteoarthritis—Epirubicin—thyroid cancer	0.00121	0.00405	CcSEcCtD
Clobazam—Increased appetite—Doxorubicin—thyroid cancer	0.00119	0.00399	CcSEcCtD
Clobazam—Asthenia—Sorafenib—thyroid cancer	0.00116	0.00387	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00115	0.0179	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00115	0.0179	CbGpPWpGaD
Clobazam—Lethargy—Doxorubicin—thyroid cancer	0.00115	0.00383	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—RXRA—thyroid cancer	0.00114	0.0179	CbGpPWpGaD
Clobazam—Pruritus—Sorafenib—thyroid cancer	0.00114	0.00381	CcSEcCtD
Clobazam—Ataxia—Epirubicin—thyroid cancer	0.00114	0.00381	CcSEcCtD
Clobazam—Diplopia—Doxorubicin—thyroid cancer	0.00112	0.00375	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—thyroid cancer	0.00112	0.00375	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—thyroid cancer	0.00112	0.00374	CcSEcCtD
Clobazam—Diarrhoea—Sorafenib—thyroid cancer	0.0011	0.00369	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00109	0.00365	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—thyroid cancer	0.00107	0.00357	CcSEcCtD
Clobazam—Dizziness—Sorafenib—thyroid cancer	0.00107	0.00356	CcSEcCtD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00106	0.0166	CbGpPWpGaD
Clobazam—Abdominal distension—Epirubicin—thyroid cancer	0.00106	0.00353	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—thyroid cancer	0.00106	0.00352	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—thyroid cancer	0.00105	0.0035	CcSEcCtD
Clobazam—Asthma—Epirubicin—thyroid cancer	0.00105	0.0035	CcSEcCtD
Clobazam—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00104	0.0162	CbGpPWpGaD
Clobazam—Eosinophilia—Epirubicin—thyroid cancer	0.00104	0.00347	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00104	0.00346	CcSEcCtD
Clobazam—Vomiting—Sorafenib—thyroid cancer	0.00103	0.00343	CcSEcCtD
Clobazam—Rash—Sorafenib—thyroid cancer	0.00102	0.0034	CcSEcCtD
Clobazam—Dermatitis—Sorafenib—thyroid cancer	0.00102	0.00339	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00101	0.00338	CcSEcCtD
Clobazam—Headache—Sorafenib—thyroid cancer	0.00101	0.00338	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—thyroid cancer	0.00101	0.00337	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—thyroid cancer	0.00099	0.00331	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—NRG1—thyroid cancer	0.00099	0.0154	CbGpPWpGaD
Clobazam—Abdominal distension—Doxorubicin—thyroid cancer	0.000977	0.00326	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000974	0.00325	CcSEcCtD
Clobazam—Asthma—Doxorubicin—thyroid cancer	0.00097	0.00324	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—thyroid cancer	0.00097	0.00324	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—thyroid cancer	0.000961	0.00321	CcSEcCtD
Clobazam—Nausea—Sorafenib—thyroid cancer	0.000958	0.0032	CcSEcCtD
Clobazam—Weight increased—Epirubicin—thyroid cancer	0.000954	0.00319	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—thyroid cancer	0.00094	0.00314	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—thyroid cancer	0.000935	0.00312	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—thyroid cancer	0.000935	0.00312	CcSEcCtD
Clobazam—Infestation—Epirubicin—thyroid cancer	0.000935	0.00312	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—thyroid cancer	0.000933	0.00312	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000927	0.0031	CcSEcCtD
Clobazam—SLC6A11—Metabolism—MINPP1—thyroid cancer	0.000915	0.0143	CbGpPWpGaD
Clobazam—Urinary tract infection—Epirubicin—thyroid cancer	0.000909	0.00303	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000902	0.00301	CcSEcCtD
Clobazam—Sweating—Epirubicin—thyroid cancer	0.000896	0.00299	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—thyroid cancer	0.000883	0.00295	CcSEcCtD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000873	0.0136	CbGpPWpGaD
Clobazam—Pneumonia—Doxorubicin—thyroid cancer	0.00087	0.00291	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—thyroid cancer	0.000865	0.00289	CcSEcCtD
Clobazam—Infestation—Doxorubicin—thyroid cancer	0.000865	0.00289	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—thyroid cancer	0.000865	0.00289	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000858	0.0134	CbGpPWpGaD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000858	0.00286	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—thyroid cancer	0.000841	0.00281	CcSEcCtD
Clobazam—Sweating—Doxorubicin—thyroid cancer	0.000829	0.00277	CcSEcCtD
Clobazam—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000817	0.0128	CbGpPWpGaD
Clobazam—Visual impairment—Epirubicin—thyroid cancer	0.000809	0.0027	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—thyroid cancer	0.000793	0.00265	CcSEcCtD
Clobazam—Eye disorder—Epirubicin—thyroid cancer	0.000784	0.00262	CcSEcCtD
Clobazam—SLC6A11—Metabolism—NDUFA13—thyroid cancer	0.000778	0.0121	CbGpPWpGaD
Clobazam—Visual impairment—Doxorubicin—thyroid cancer	0.000748	0.0025	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000744	0.0116	CbGpPWpGaD
Clobazam—Mental disorder—Epirubicin—thyroid cancer	0.000735	0.00246	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—thyroid cancer	0.000734	0.00245	CcSEcCtD
Clobazam—SLC6A11—Metabolism—CHST14—thyroid cancer	0.000731	0.0114	CbGpPWpGaD
Clobazam—Malnutrition—Epirubicin—thyroid cancer	0.000731	0.00244	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—thyroid cancer	0.000726	0.00242	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000723	0.0113	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—CP—thyroid cancer	0.000723	0.0113	CbGpPWpGaD
Clobazam—Tension—Epirubicin—thyroid cancer	0.000717	0.00239	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000711	0.0111	CbGpPWpGaD
Clobazam—Nervousness—Epirubicin—thyroid cancer	0.00071	0.00237	CcSEcCtD
Clobazam—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000709	0.0111	CbGpPWpGaD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000707	0.011	CbGpPWpGaD
Clobazam—Muscle spasms—Epirubicin—thyroid cancer	0.000702	0.00235	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000691	0.0108	CbGpPWpGaD
Clobazam—Vision blurred—Epirubicin—thyroid cancer	0.000688	0.0023	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—thyroid cancer	0.00068	0.00227	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000679	0.0106	CbGpPWpGaD
Clobazam—Malnutrition—Doxorubicin—thyroid cancer	0.000676	0.00226	CcSEcCtD
Clobazam—Anaemia—Epirubicin—thyroid cancer	0.000675	0.00226	CcSEcCtD
Clobazam—Agitation—Epirubicin—thyroid cancer	0.000671	0.00224	CcSEcCtD
Clobazam—Tension—Doxorubicin—thyroid cancer	0.000663	0.00222	CcSEcCtD
Clobazam—Nervousness—Doxorubicin—thyroid cancer	0.000657	0.00219	CcSEcCtD
Clobazam—Leukopenia—Epirubicin—thyroid cancer	0.000654	0.00218	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—thyroid cancer	0.00065	0.00217	CcSEcCtD
Clobazam—Cough—Epirubicin—thyroid cancer	0.000637	0.00213	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—thyroid cancer	0.000637	0.00213	CcSEcCtD
Clobazam—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000626	0.00976	CbGpPWpGaD
Clobazam—Anaemia—Doxorubicin—thyroid cancer	0.000625	0.00209	CcSEcCtD
Clobazam—Myalgia—Epirubicin—thyroid cancer	0.000622	0.00208	CcSEcCtD
Clobazam—Agitation—Doxorubicin—thyroid cancer	0.000621	0.00207	CcSEcCtD
Clobazam—Anxiety—Epirubicin—thyroid cancer	0.00062	0.00207	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000618	0.00206	CcSEcCtD
Clobazam—Dry mouth—Epirubicin—thyroid cancer	0.000608	0.00203	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—thyroid cancer	0.000605	0.00202	CcSEcCtD
Clobazam—Confusional state—Epirubicin—thyroid cancer	0.000601	0.00201	CcSEcCtD
Clobazam—Infection—Epirubicin—thyroid cancer	0.000592	0.00198	CcSEcCtD
Clobazam—Cough—Doxorubicin—thyroid cancer	0.00059	0.00197	CcSEcCtD
Clobazam—SLC6A11—Metabolism—HPGD—thyroid cancer	0.00059	0.0092	CbGpPWpGaD
Clobazam—Nervous system disorder—Epirubicin—thyroid cancer	0.000585	0.00195	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—thyroid cancer	0.000584	0.00195	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000583	0.00909	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000583	0.00909	CbGpPWpGaD
Clobazam—Skin disorder—Epirubicin—thyroid cancer	0.000579	0.00193	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—thyroid cancer	0.000576	0.00192	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—thyroid cancer	0.000575	0.00192	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—thyroid cancer	0.000573	0.00192	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000573	0.00895	CbGpPWpGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000572	0.00191	CcSEcCtD
Clobazam—Anorexia—Epirubicin—thyroid cancer	0.000568	0.0019	CcSEcCtD
Clobazam—Dry mouth—Doxorubicin—thyroid cancer	0.000563	0.00188	CcSEcCtD
Clobazam—Hypotension—Epirubicin—thyroid cancer	0.000557	0.00186	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—thyroid cancer	0.000556	0.00186	CcSEcCtD
Clobazam—Infection—Doxorubicin—thyroid cancer	0.000548	0.00183	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000547	0.00854	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000543	0.00181	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000541	0.00845	CbGpPWpGaD
Clobazam—Nervous system disorder—Doxorubicin—thyroid cancer	0.000541	0.00181	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00054	0.0018	CcSEcCtD
Clobazam—Insomnia—Epirubicin—thyroid cancer	0.000539	0.0018	CcSEcCtD
Clobazam—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000536	0.00836	CbGpPWpGaD
Clobazam—Skin disorder—Doxorubicin—thyroid cancer	0.000536	0.00179	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000533	0.00178	CcSEcCtD
Clobazam—Somnolence—Epirubicin—thyroid cancer	0.00053	0.00177	CcSEcCtD
Clobazam—Anorexia—Doxorubicin—thyroid cancer	0.000526	0.00176	CcSEcCtD
Clobazam—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000523	0.00816	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—BRAF—thyroid cancer	0.00052	0.00812	CbGpPWpGaD
Clobazam—Decreased appetite—Epirubicin—thyroid cancer	0.000518	0.00173	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—thyroid cancer	0.000515	0.00172	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000515	0.00172	CcSEcCtD
Clobazam—Fatigue—Epirubicin—thyroid cancer	0.000514	0.00172	CcSEcCtD
Clobazam—Constipation—Epirubicin—thyroid cancer	0.00051	0.0017	CcSEcCtD
Clobazam—GABRB2—Orphan transporters—RXRA—thyroid cancer	0.000508	0.00793	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000503	0.00168	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—thyroid cancer	0.000499	0.00167	CcSEcCtD
Clobazam—Feeling abnormal—Epirubicin—thyroid cancer	0.000491	0.00164	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—thyroid cancer	0.00049	0.00164	CcSEcCtD
Clobazam—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000489	0.00763	CbGpPWpGaD
Clobazam—Decreased appetite—Doxorubicin—thyroid cancer	0.00048	0.0016	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000476	0.00159	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—thyroid cancer	0.000476	0.00159	CcSEcCtD
Clobazam—Urticaria—Epirubicin—thyroid cancer	0.000474	0.00158	CcSEcCtD
Clobazam—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000473	0.00738	CbGpPWpGaD
Clobazam—Constipation—Doxorubicin—thyroid cancer	0.000472	0.00158	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—thyroid cancer	0.000471	0.00157	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000466	0.00727	CbGpPWpGaD
Clobazam—GABRG2—Orphan transporters—RXRA—thyroid cancer	0.000465	0.00725	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000464	0.00724	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000459	0.00717	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000455	0.0071	CbGpPWpGaD
Clobazam—Feeling abnormal—Doxorubicin—thyroid cancer	0.000455	0.00152	CcSEcCtD
Clobazam—Urticaria—Doxorubicin—thyroid cancer	0.000438	0.00146	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000436	0.00681	CbGpPWpGaD
Clobazam—Body temperature increased—Doxorubicin—thyroid cancer	0.000436	0.00146	CcSEcCtD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000429	0.00669	CbGpPWpGaD
Clobazam—Asthenia—Epirubicin—thyroid cancer	0.000428	0.00143	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000427	0.00666	CbGpPWpGaD
Clobazam—Pruritus—Epirubicin—thyroid cancer	0.000422	0.00141	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—BRAF—thyroid cancer	0.000419	0.00654	CbGpPWpGaD
Clobazam—Diarrhoea—Epirubicin—thyroid cancer	0.000408	0.00136	CcSEcCtD
Clobazam—GABRA1—Orphan transporters—RXRA—thyroid cancer	0.000406	0.00634	CbGpPWpGaD
Clobazam—Asthenia—Doxorubicin—thyroid cancer	0.000396	0.00132	CcSEcCtD
Clobazam—Dizziness—Epirubicin—thyroid cancer	0.000394	0.00132	CcSEcCtD
Clobazam—Pruritus—Doxorubicin—thyroid cancer	0.00039	0.0013	CcSEcCtD
Clobazam—Vomiting—Epirubicin—thyroid cancer	0.000379	0.00127	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—thyroid cancer	0.000377	0.00126	CcSEcCtD
Clobazam—Rash—Epirubicin—thyroid cancer	0.000376	0.00126	CcSEcCtD
Clobazam—CYP2C18—Biological oxidations—RXRA—thyroid cancer	0.000376	0.00586	CbGpPWpGaD
Clobazam—Dermatitis—Epirubicin—thyroid cancer	0.000376	0.00125	CcSEcCtD
Clobazam—Headache—Epirubicin—thyroid cancer	0.000374	0.00125	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000367	0.00572	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000366	0.00571	CbGpPWpGaD
Clobazam—Dizziness—Doxorubicin—thyroid cancer	0.000365	0.00122	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000363	0.00567	CbGpPWpGaD
Clobazam—Nausea—Epirubicin—thyroid cancer	0.000354	0.00118	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—thyroid cancer	0.000351	0.00117	CcSEcCtD
Clobazam—Rash—Doxorubicin—thyroid cancer	0.000348	0.00116	CcSEcCtD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000348	0.00543	CbGpPWpGaD
Clobazam—Dermatitis—Doxorubicin—thyroid cancer	0.000348	0.00116	CcSEcCtD
Clobazam—Headache—Doxorubicin—thyroid cancer	0.000346	0.00115	CcSEcCtD
Clobazam—SLC6A11—Metabolism—TPR—thyroid cancer	0.000339	0.00528	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PRKAR1A—thyroid cancer	0.000333	0.0052	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—thyroid cancer	0.000328	0.00109	CcSEcCtD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000324	0.00506	CbGpPWpGaD
Clobazam—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000322	0.00503	CbGpPWpGaD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000315	0.00491	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000312	0.00487	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000284	0.00444	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—MINPP1—thyroid cancer	0.000276	0.00431	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000263	0.0041	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SLC5A5—thyroid cancer	0.000253	0.00396	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000252	0.00393	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000246	0.00384	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—HRAS—thyroid cancer	0.000239	0.00373	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NDUFA13—thyroid cancer	0.000235	0.00366	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000228	0.00355	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000225	0.00352	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CHST14—thyroid cancer	0.000221	0.00344	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000218	0.0034	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000218	0.0034	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—RXRA—thyroid cancer	0.000213	0.00332	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000197	0.00308	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000197	0.00308	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000197	0.00307	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000195	0.00304	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000194	0.00303	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000194	0.00303	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—HRAS—thyroid cancer	0.000193	0.00301	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000186	0.00291	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000185	0.00289	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000185	0.00288	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00018	0.00282	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00018	0.00282	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—HPGD—thyroid cancer	0.000178	0.00278	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000177	0.00277	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000169	0.00264	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000158	0.00247	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000158	0.00246	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000158	0.00246	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000155	0.00242	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000148	0.00232	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000148	0.00231	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000148	0.0023	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—BRAF—thyroid cancer	0.000142	0.00221	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.00014	0.00218	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.000136	0.00212	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000135	0.00211	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPARG—thyroid cancer	0.000134	0.0021	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—BRAF—thyroid cancer	0.00013	0.00203	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000125	0.00196	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000124	0.00194	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000118	0.00184	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NDUFA13—thyroid cancer	0.000115	0.0018	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000113	0.00177	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—BRAF—thyroid cancer	0.000113	0.00177	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000113	0.00177	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CHST14—thyroid cancer	0.000108	0.00169	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTGS2—thyroid cancer	0.000106	0.00165	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000104	0.00162	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000103	0.0016	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TPR—thyroid cancer	0.000102	0.00159	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	0.000101	0.00157	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—MINPP1—thyroid cancer	0.0001	0.00156	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.92e-05	0.00155	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTEN—thyroid cancer	9.22e-05	0.00144	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	9.05e-05	0.00141	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—HPGD—thyroid cancer	8.75e-05	0.00136	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NDUFA13—thyroid cancer	8.72e-05	0.00136	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—HRAS—thyroid cancer	8.51e-05	0.00133	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NDUFA13—thyroid cancer	8.51e-05	0.00133	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—RXRA—thyroid cancer	8.39e-05	0.00131	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CHST14—thyroid cancer	8.2e-05	0.00128	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CHST14—thyroid cancer	8e-05	0.00125	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.91e-05	0.00123	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	7.91e-05	0.00123	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—HRAS—thyroid cancer	7.79e-05	0.00122	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.78e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SLC5A5—thyroid cancer	7.65e-05	0.00119	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.32e-05	0.00114	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.81e-05	0.00106	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—HPGD—thyroid cancer	6.61e-05	0.00103	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—HRAS—thyroid cancer	6.52e-05	0.00102	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—HPGD—thyroid cancer	6.45e-05	0.00101	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—RXRA—thyroid cancer	6.43e-05	0.001	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	6.22e-05	0.000971	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—MINPP1—thyroid cancer	6.17e-05	0.000962	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—HRAS—thyroid cancer	5.97e-05	0.000931	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.92e-05	0.000924	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.62e-05	0.000878	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.43e-05	0.000847	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.36e-05	0.000837	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKT1—thyroid cancer	5.32e-05	0.00083	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NDUFA13—thyroid cancer	5.24e-05	0.000818	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—HRAS—thyroid cancer	5.22e-05	0.000814	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TPR—thyroid cancer	5.02e-05	0.000784	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.97e-05	0.000776	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	4.94e-05	0.000771	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CHST14—thyroid cancer	4.93e-05	0.000769	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.17e-05	0.00065	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPARG—thyroid cancer	4.06e-05	0.000633	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—HPGD—thyroid cancer	3.97e-05	0.00062	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TPR—thyroid cancer	3.8e-05	0.000592	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.76e-05	0.000587	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.73e-05	0.000583	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TPR—thyroid cancer	3.7e-05	0.000578	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.7e-05	0.000578	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.64e-05	0.000569	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.38e-05	0.000528	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTGS2—thyroid cancer	3.19e-05	0.000498	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—RXRA—thyroid cancer	3.16e-05	0.000493	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.13e-05	0.000488	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.84e-05	0.000443	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTEN—thyroid cancer	2.78e-05	0.000434	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.77e-05	0.000433	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.66e-05	0.000416	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—RXRA—thyroid cancer	2.39e-05	0.000373	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—RXRA—thyroid cancer	2.33e-05	0.000364	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.32e-05	0.000362	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TPR—thyroid cancer	2.28e-05	0.000356	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.25e-05	0.00035	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPARG—thyroid cancer	1.99e-05	0.000311	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.71e-05	0.000267	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKT1—thyroid cancer	1.6e-05	0.00025	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.57e-05	0.000245	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000235	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPARG—thyroid cancer	1.47e-05	0.00023	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—RXRA—thyroid cancer	1.44e-05	0.000224	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000214	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000185	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.000181	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTEN—thyroid cancer	1.03e-05	0.000161	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000158	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPARG—thyroid cancer	9.06e-06	0.000141	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKT1—thyroid cancer	7.89e-06	0.000123	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.13e-06	0.000111	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTEN—thyroid cancer	6.22e-06	9.7e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKT1—thyroid cancer	5.96e-06	9.3e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKT1—thyroid cancer	5.82e-06	9.08e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKT1—thyroid cancer	3.58e-06	5.59e-05	CbGpPWpGaD
